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Abstrak—The material used in this research was dry powder of 
pericarp mangosteen (Garcinia mangostana Linn.). which is a 
family plant of Clusiaceae. This taxa is known as the main source 
of prenylated xanthones derived from phenolic compounds. The 
compounds separation process was carried out by maceration 
method, 8 kg of sample macerated using n-hexane solvent, 90 g of 
n-hexane extract were produced. The n-hexane extract was 
fractionated by vacuum liquid chromatography (VLC) using silica 
gel, eluted by increasing the polarity of the solvent, which is a 
mixture of n-hexane solvent: dichloromethane (10%, 20%, 30% 
and 50%), resulting in three combined fractions, namely the first 
fraction 13,92 g, the second fraction 18,27 g, and the third fraction 
23,24 g. The refraction process was then carried out in the third 
fraction, producing two yellow crystals with melting points 
respectively, 155-156 °C and 172-173 °C. The structural 
elucidation method was carried out using UV-Vis, IR, HR-ESI-
MS, and NMR spectroscopy techniques. Based on the analysis of 
spectrum data from two known compounds, 8-deoxygartanin (1) 
and β-mangostin (2) antidiabetic bioactivity test was carried out 
by the method of inhibiting the enzyme α-glucosidase in vitro. The 
test results obtained by compound (1) with an IC50 value of 38,5 
μM and compound (2) with an IC50 value of 157,9 μM indicate that 
the two compounds are included in the inactive category. This is 
indicated by the IC50 value which is much higher when compared 
to the acarbose as a positive control with an IC50 value of 4.5 μM.  
 
Kata Kunci—Garcinia mangostana Linn, Isolation, antidiabetic. 
I. INTRODUCTION 
ROUND 30,000 types of medicinal plants are known in 
Indonesia and 25% of them are known to have herbal 
properties. Data from the World Health Organization (World 
Helath Organization, WHO) in 2001 revealed that 80% of 
Indonesia's population consumed herbal medicines. This 
consumption nationally increases an average of 5% per year 
based on the combined data of Indonesian herbal medicine and 
medicine entrepreneurs in 2018 [1]. This encourages scientists 
to continue to conduct research and exploration of various types 
of plants. Taksa Garcinia is a group of plants from the 
clusiaceae family which is estimated to have around 418 
species, and 64 of them are scattered in the territory of 
Indonesia. Where the largest population is from Garcinia 
mangostana Linn. or commonly known as fruit plants, namely 
Mangosteen [2]. Mangosteen thrives in areas with high 
humidity and relatively short summers such as Indonesia. This 
plant lives at an altitude of 1000 m (20-40 oC) in the tropics and 
grows optimally in the lower plains. Mangosteen is widely used 
in health fields such as stomach pain, chronic ulcers, infected 
wounds, pus, diarrhea, cancer, heart disease and other 
degenerative diseases. Mangosteen also shows antiviral, anti-
inflammatory, antibacterial, antioxidant, antitumoral, and 
hypo-allergenic activity [3-4]. 
The various benefits and activities are due to the presence of 
secondary metabolite compounds contained in the Mangosteen 
plant. Secondary metabolites generally act as attractants, 
protectants, and repellants to various environmental conditions. 
Secondary metabolite compounds also specifically function as 
a protective plant against biotic pressure (bacteria, fungi, 
nematodes, insects, or other animals) and abiotics (temperature 
and humidity) [5-6]. Secondary metabolites in the mangosteen 
plant are generally in the form of flavonoids, tannins and 
xanthones, where xanthones are found in the mangosteen rind. 
Santon is a polyphenol with a unique and attractive structure in 
the form of aromatic with three cyclic, C6-C3-C6 [7]. 
Exploration of secondary metabolite compounds from 
various plant sources is very important to be continuously 
carried out and tested for its bioactivity due to the increasing 
need for medicinal preparations, so a bioactivity test method is 
needed in order to see the activeness of a compound. The 
literature review informs that so far there have been no reports 
of antidiabetic activity testing of the β-mangostin and 8-
deoxygartanin compounds. Based on this, this research was 
formulated to isolate secondary metabolite compounds from 
pericarp of mangosteen extract in the form of β-mangostin and 
8-deoxygartanin. Subsequent research was followed by an α-
glucosidase enzyme inhibitory activity test. 
II. MATERIALS AND METHOD 
A. Material 
The equipment used in this study were glass beaker 
equipment, two neck flasks (5 mL and 10 mL), Merck TLC 
plate with 60 F254 silica gel (Merck KGaA 64271, Darmstadt, 
Germany), digital balance (Fujitsu FS-AR210, Japan) , reflux 
(steam bath), percolator, Cimarec hot plate (SP131320-33, 
China), maceration tube (maserator), rotary evaporator (Buchi 
R-210, Switzerland), Fisher John melting point Apparatus 
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(Philip Haris, USA), equipment vacuum liquid chromatography 
(KCV), gravity column chromatography (KKG), sephadex 
column chromatography, UV lamps (λ = 254 and 366 nm), UV-
Vis Genesys 10S spectrometers (Thermofisher, USA), FT-IR 
spectrophotometer (Shimadzu 8400S, Japan), HR-EI-MS 
(ThermoFinnigan, Bremen, Germany) and 1H-NMR and 13C-
NMR (1D) spectrometers (JEOL ECS, 400 MHz, Japan). 
The materials used in the study were dried pericarp of 
mangosteen (G. mangostana L.), n-hexane solvent, 
dichloromethane, ethyl acetate, methanol, aquades, 
hydrochloric acid, 99% ethanol, Merck 60 G silica gel for KCV, 
silica gel 60 (70-230 mesh) for KKG, silica gel 60 GF254 as a 
stationary phase on the TLCp plate, reagent visibility of cerium 
sulfate (Ce(SO4)2) 1.5% in sulfuric acid (H2SO4) 2N, shear 
reagents for UV test namely NaOH, AlCl3 and HCl, acetone-
d6, methanol-d4, dimethyl sulfoxide-d6 and tetramethylsilane 
(TMS) as a reference, and potassium bromide for IR testing. 
B. Isolation 
1) Preliminary Test 
The preliminary test is carried out as initial data or as a 
reference for the next stage of the separation process. The 
important thing to note in this process is determining the type 
of solvent to be used and how effective the solvent is in the 
extraction process. Samples of dried pericarp of mangosteen 
(G. mangostana L.) peels were milled into four vial bottles (100 
mL) of each bottle of 10 grams. Then the extraction process was 
carried out by maceration method for 24 hours using different 
solvents (n-hexane, dichloromethane, ethyl acetate and 
methanol) for each vial vial. 
2) Extraction and Fractionation 
Dry sample powder (8 kg) was extracted by maceration 
method using n-hexane solvent for 3x24 hours at room 
temperature. Next, a filtering process is carried out to obtain the 
filtrate, then the filtrate is evaporated using the Eyela N-100 
rotary evaporator. This process aims to separate the filtrate from 
the solvent, so that a thick extract of the sample is obtained. 
The next process is fractionation, where the first 
fractionation is used vacuum liquid chromatography (VLC). 
The stationary phase used is 60G silica gel and the mobile phase 
is in the form of an eluent (done with an increasing polarity 
system). From the results of VLC fractionation obtained 
fractions that are accommodated in vial bottles (300 mL), then 
at thin layer chromatography (TLC) and observed its separation 
 
Figure 1. UV- Vis spectrum of compound 1 in MeOH and with the 
addition of NaOH shear reagents. 
 
 
Figure 2. UV-Vis spectrum of compound 1 in MeOH solvents and with 

































Figure 5. Suggested structural framework for compound 1 results from 




profile. The fractions that have the same retention factor (Rf) 
value are combined, so that a smaller number of fractions will 
be obtained. The second fractionation was carried out using the 
gravity column chromatography (GCC) method. The selected 
fraction (chosen based on observations of the chromatogram) 
from the VLC fractionation was fractionated with GGC using 
70-230 mesh silica gel as the stationary phase. From the GGC 
results fractions will be obtained (the same treatment as the 
VLC). The end result of the fractionation separation process is 
expected to be a pure compound. The purity test was carried out 
by the 3-system system TLC, the 2D TLC and the melting point 
test. 
C. Characterization of The Isolated Metabolites 
The pure compounds obtained were determined using 
ultraviolet visible (UV-Vis), infrared (IR), mass (MS), and 
Nuclear Magnetic Resonance (NMR) spectroscopy. 
D. Antidiabetic Test 
The antidiabetic test is carried out by the α-glucosidase 
inhibition test method [8]. using rat intestinal acetone powder, 
buffer phosphate solution (pH 6.9), and a substrate in the form 
of sucrose. The test process was carried out by adding 10 μL 
DMSO to eppendorf 1-4 followed by the addition of 50 μL 
buffer phosphate (pH 6.9) to eppendorf 1 and 3, and 30 μL 
buffer phosphate (pH 6.9) to eppendorf 2 and 4. Sucrose 
substrate (20 μL) was then added to eppendorf 2 and 4. Glucose 
kit (80 μL) and enzyme (20 μL) were then added to all 
eppendorf, and eppendorf was incubated for 10 minutes at 37 
°C. After incubation, absorption is measured at wavelength (λ) 
520 nm. Inhibitory activity (%) can be calculated through the 
equation: 
Inhibition (%) = [
𝐴.𝑏𝑙𝑎𝑛𝑘−𝐴.𝑠𝑎𝑚𝑝𝑙𝑒
𝐴.𝑏𝑙𝑎𝑛𝑘
] × 10……………… (1) 
III. RESULTS AND DISCUSSION 
A. Preliminary Test 
The preliminary test in this study aims to find out the right 
solvent in the extraction process. The extraction results of the 
pericarp of mangosteen (G. mangostana L.) obtained was then 
monitored by the TLC method to see the profile of the stain. 
Appears on the TLC chromatogram showing a good separation 
profile of the compound, namely the n-hexane solvent. 
Therefore, in the sample extraction process an n-hexane solvent 
will be used. 
 
Figure 6. Compounds (1). 
 
Figure 7. UV-Vis spectrum of compound 2 in MeOH solvents and with 



























NMR 8-deoxygartanin data and compound 1 in acetone d6 
Position 
8-deoxygartanin Compound 1 
δH δC δH δC 
1 - 159.8 - 158.8 
2 - 111.6 - 111.6 
3 - 162.0 - 162.4 
4 - 107.8 - 107.7 
4a - 153.9 - 153.6 
4b - 146.8 - 145.0 
5 - 147.6 - 154.2 
6 
7.38 (1H, dd, 
J=7.9 and 1.6) 
121.6 




7.26 (1H, t, 
J=7.9) 
124.9 




7.70 (1H, dd, 
J=7.9 and 1.6) 
116.6 
7.65 (1H, dd, J 
= 8.0 and 1.3) 
109.9 
8a - 122.5 - 122.9 
9 - 182.5 - 185.9 
9a - 104.2 - 102.7 
1’ 
3.46 (2H, s, 
J=7.0) 
22.8 








5.24 (1H, t, 
J=7.0) 
124.6 
3’ - 133.0 - 138.0 
4’ 1.67 (3H, d) 26.3 1.76 (3H, s) 26.0 





3.69 (2H, s, 
J=7.0) 
22.5 




5.25 (t, J=7.0 
and 1.3) 
123.4 5.18 (t, J=7.0) 122.7 
8’ - 132.9 - 132.8 
9’ 1.66 (3H) 26.2 1.82 (3H, d) 25.9 
10’ 1.80 (3H) 18.4 2.01 (3H, m) 18.0 
1-OH 13.33 (1H, s) - 13.29 (1H, s) - 
3-OH 6.58 (1H, s) - 12.29 (1H, s) - 




B. Extraction and Fractionation 
8 kg of samples was macerated for 3x24 hours. Maceration 
results obtained liquid extract which is then evaporated using 
an evaporator and obtained a weight of 90 grams (1.125%). 
Furthermore, fractionation by the liquid-vacuum VLC method 
uses a mixture of n-hexane and methylene chloride solvent. The 
VLC process is carried out with an increasing polarity system, 
which increases eluent polarity. The result was obtained as 
many as 70 fractions, which then the factions were monitored 
by TLC, stains that have the same Rf combined. In fraction 3 
yellow crystal are formed, so they are separated from the 
solvent by vacuum filtering. The crystal obtained was coded 
crystal 1 (3A) as much as 84.20 mg, while the solvent was 
coded 3B. Furthermore, the combined fraction was evaporated 
with a rotary evaporator, to obtain 3 combined fractions, 
namely 1 (13.92 g), 2 (18.27 g) and 3B (23.24 g). 
The 3B fraction of 23.24 g was fractionated again by the 
VLC method. The results of this fractionation obtained by 
crystal and coded crystal 2 (3B5A) of 674.30 mg. Furthermore, 
the other fractions are combined based on the stain profile, to 
obtain 5 combined fractions, namely 3B1 (0.84 g), 3B2 (0.83 
g), 3B3 (3.31 g), 3B4 (3.55 g) and 3B5B (6.09 g). The fractions 
of 3B3 (3.31 g) and 3B4 (3.55 g) were further fractionated by 
the sephadex column chromatography method. Sephadex 
column chromatography is a fractionation method based on 
differences in molecular size of compounds. Fractionation was 
carried out using methylene chloride-methanol (50%) eluent. 
The results of fractionation of sephadex column produced 5 
main fractions for 3B3, namely 3B3A (20.20 mg), 3B3B 
(361.60 mg), 3B3C (158.60 mg), 3B3D (1.23 g) and 3B3E 
(1.34 g) ) and 4 main fractions for 3B4, namely 3B4A (180.70 
mg), 3B4B (381.80 mg), 3B4C (382.20 mg) and 3B4D (1.11 g). 
The 3B3E (1.34 g) and 3B4D (1.11 g) fractions was combined 
because they had a similar Rf value and were named the "X" 
fraction, then was refracted by the GCC method, so that 5 main 
fractions (X1-X5). The results of this fractionation produced 
two crystal, namely crystal 3 as much as 256.50 mg and crystal 
4 as much as 290 mg, each of which came from fractions X4 
and X5. 
Crystal purity test 1 (3A), crystal 2 (3B5A), crystal 3 (x4) 
and crystal 4 (x5) with TLC method 3 eluent system obtained a 
single stain appearance on each different eluent. The melting 
points of crystals are 155-156 °C, 156-157 °C, 155-156 °C and 
172-173 °C, respectively. Crystals 1 (3A), 2 (3B5A), and 3 (x4) 
have similarities in terms of shape, color, melting point and Rf 
value, so that the three crystals are inferred to be the same 
crystal and coded as compound 1. Meanwhile, crystals 4 is 
different from other crystals, so it is coded compound 2.  
 














Figure 10. Suggested structural framework for compound 2 results from 
spectrum analysis (UV-Vis and IR). 
 
 





















Data NMR β-mangostin and compound 2 
Position 
β-mangostin Compound 2 
δH δC δH δC 
1 - 160.5 - 163.2 
2 - 111.8 - 110.3 
3 - 164.6 - 158.9 
4 6.47 (s) 89.9 6.55 (s, 1H) 89.5 
4a - 157.5 - 157.2 
4b - 156.2 - 154.7 
5 6.83 (s) 102.7 6.79 (s, 1H) 102.7 
6 - 156.3 - 154.7 
7 - 144.6 - 143.5 
8 - 138.2 - 136.5 
8a - 112.2 - 110.3 
9 - 182.9 - 181.5 
9a - 104.2 - 102.7 
10 3.95 (s) 61.4 3.86 (s, 3H) 60.2 





3.18 (d, J=7.1, 
2H) 
25.7 
2’ 5.22 (t) 123.4 5.09 (t, 1H) 122.2 
3’ - 131.5 - 130.8 
4’ 1.77 (s) 25.9 1.69 (s, 3H) 25.6 
5’ 1.82 (s) 18.3 1.75 (s, 3H) 17.6 
6’ 4.12 (d, J=6.5) 21.9 
3.98 (d, J=6.5, 
2H) 
20.9 
7’ 5.28 (t) 124.7 5.13 (t, 1H) 123.6 
8’ - 131.5 - 130.5 
9’ 1.63 (s) 17.9 1.58 (s, 3H) 18.0 
10’ 1.65 (s) 26.9 1.59 (s, 3H) 25.7 
1-OH 13.61 (s) - 13.56 (s, 1H) - 





C. Characterization of the Isolated Metabolites 
1) Compound 1 
Compound 1 was identified using UV-Vis, IR, 1H-NMR and 
13C-NMR spectroscopic methods. The UV-Vis spectrum of 
compound 1 shows the presence of two peaks at wavelengths 
(λ) of 258 nm and 352 nm (Figure 1). The absorption peak at λ 
258 nm indicates the electron transition π → π * which is a 
typical chromophore conjugated double bond (-C=C-C=C-) 
aromatic ring and the 352 nm absorption peak shows the 
electron transition n → π * heteroatom that is conjugated with 
a bond duplicate (-C=C-C=O). These data provide an initial 
conclusion that compound 1 contains an aromatic system 
substituted for ketones. 
Further testing is carried out using UV shear reagents to 
determine the position of the substituted hydroxy group located 
in the ortho- or para- position. The addition of NaOH shear 
reagents caused a batochromic shift where the peak at λ 258 nm 
shifted to 276 nm and the peak at λ 352 nm shifted to 378 nm. 
The existence of this peak shift informs that the hydroxy group 
is substituted in a para-position due to keto-enol equilibrium. 
Furthermore, the addition of AlCl3 shear reagents also caused a 
batochromic shift, the peak at λ 352 nm shifted to 368 nm and 
the peak at λ 258 nm shifted to 266 nm (Figure 2). This shift 
indicates that compound 1 is substituted by a hydroxy group (-
OH) which is chelated with carbonyl (-C=O). The addition of 
HCl shear reagents subsequently did not cause a shift in the 
absorption peak. This indicates that in crystal 1 there is a 
hydroxy group chelated with carbonyl under stable conditions. 
Analysis of UV-Vis compound 1 gives a provisional conclusion 
containing a hydroxy group (-OH) in the para- position of the 
carbonyl suggested that keto-enol or tautomery equilibrium in 
the aromatic ring is expected (Figure 3). 
IR spectroscopic analysis of compound 1 as can be seen in 
Figure 4. shows the absorption band at the wave number (v, cm-
1) 3404 cm-1 which characterizes the presence of a hydroxy 
group (-OH) and absorption band at 1629 cm-1 which is suitable 
for the group carbonyl (C=O) chelated -OH group, typical for 
phenolic or xanthone skeletons [9-10]. The IR analysis data 
supports the results of the analysis using UV-Vis spectroscopy 
which shows the absorption peak at λ 352 nm which indicates 
the existence of a heteroatomic conjugation system in the 
aromatic ring. IR spectrum data of compound 1 also gave 
absorption bands at 2970 cm-1, 2922 cm-1, and 2854 cm-1 which 
are methyl groups (aliphatic -CH). Other absorption bands were 
also seen at 1581 cm-1, 1491 cm-1, 1381 cm-1, 1338 cm-1, which 
showed a double bond in the aromatic ring, reinforcing UV-Vis 
data at λ 258 nm [11-12]. Then, the absorption band at 1220 cm-
1 is suitable for the ether group (C-O). The results of the 
combined UV-Vis and IR analysis can be suggested that 
compound 1 has: the basic framework of xanthone compounds 
containing chelated hydroxy groups with carbonyl groups in the 
ortho position and hydroxy groups in the para-to carbonyl 
position, as shown in (Figure 5). 
Identification of compound 1 was followed by mass 
spectroscopy (High Resolution Electrospray Ionization Mass 
Spectrometry, HR-ESI-MS). The spectrum shows a peak at m/z 
381.2993 [M + H]+. Based on these data, it can be assumed that 
 




IC50 value (μM) 8-deoxygartanin (1), β-mangostin (2), dan acarbose (+) 








312.50 2.495 83.22 73.88 - 
156.25 2.194 70.28 61.98 - 
78.12 1.893 68.88 59.75 - 
39.06 1.592 64.34 42.75 - 
19.53 1.291 52.40 26.77 - 
9.77 0.990 44.18 14.98 - 
Y 24.05x + 21.98 39.59x – 22.29 - 
R2 0.9553 0.9704 - 
IC50 (μM) 38.5 157.9 4.5 




compound 1 has the molecular formula C23H25O5 from the 
calculation of MS 381,3005 with a DBE value of 11.5. Further 
structural identification using 1H-NMR spectroscopy (400 
MHz, acetone d6), continuing the results of UV-Vis, IR and 
HR-ESI-MS analysis of xanthone compounds showed the 
presence of an unshielded singlet signal (downfield) on 
chemical shifts (δH) 13.29 ppm which is suitable for one proton 
chelate hydroxy group on a C-1 atom. Furthermore, three 
aromatic protons appear as doublets of doublet at δH 7.65 ppm, 
7.22 ppm, and 6.58 ppm. Two free hydroxy protons each appear 
as singlets at δH 12.29 ppm and 11.27 ppm. The 1H-NMR 
spectrum of compound 1 also showed the presence of two 
prenyl substituents which were marked by the presence of two 
doublet signals at δH 3.62 ppm and 3.40 ppm which were 
suitable for two methylene protons, two triplet signals at δH 
5.24 ppm and 5.18 ppm, each corresponding to one methyl 
proton, and four signals that appear at δH 2.01 ppm, 1.82 ppm, 
1.76 ppm, and 1.63 ppm which are suitable for twelve proton 
methyl groups. The 13C-NMR spectrum (101 MHz, acetone d6) 
showed 23 peaks, namely 185.9; 162.4; 158.8; 154.2; 153.6; 
145.0; 138.0; 132.7; 132.8; 124.6; 122.9; 122.7; 111.6; 109.9; 
108.3; 107.7; 102.7; 26.0; 25.9; 22.2; 22.0; 18.1; 18.0. 
Furthermore, comparison of NMR data for compound 1 with 
NMR data for compound 8-deoxygartanin [13] as tabulated in 
Table 1. shows similarities between the two. Based on UV-Vis, 
IR, HR-ESI-MS, 1H-NMR and 13C-NMR spectroscopy it can 
be concluded that compound 1 has one chelate hydroxy group, 
two free hydroxy groups, and two prenil groups which are 8-
deoxygartanin compounds (1) and can see Figure 6 
2) Compound 2 
The UV-Vis spectrum of compound 2 shows the presence of 
two peaks at wavelengths (λ) of 242 nm and 314 nm (Figure 7). 
As in compound 1 the two absorption peaks indicate that 
compound 2 contains an aromatic system substituted for 
ketones (Figure 8). Compound 2 does not contain a hydroxy 
group (-OH) in the para-to carbonyl position because at the time 
of addition of the NaOH and AlCl3 shear reagents there is no 
batochromic shift.  
IR spectroscopic analysis of compound 2 as can be seen in 
Figure 9. shows absorption bands similar to compound 1 which 
are characteristic of derivatives of xanthones [9-10], [12]. The 
results of the IR analysis provide the second conclusion that 
compound 2 has a framework of xanthone compounds 
containing chelated hydroxy groups with carbonyl groups at the 
ortho position (Figure 10). 
Identification of compound 2 is followed by High Resolution 
Electrospray Ionization Mass Spectrometry, HR-ESI-MS. The 
MS spectrum shows a peak at m/z 425,2026 [M + H]+. Based 
on these data, it can be assumed that compound 2 has the 
molecular formula C25H29O6 from the calculation of MS 
425,1964 with a DBE value of 11.5. 
Further structural identification using 1H-NMR spectroscopy 
(400 MHz, DMSO d6), continuing the results of UV-Vis, IR, 
HR-ESI-MS analysis of xanthone compounds showed signals 
similar to compound 1. However, there were slight differences 
in the number of peaks, where there are more peaks that appear. 
The peak appears as a singlet at δH 8.28 ppm which is free 
hydroxy. At δH 3.86 ppm and 3.68 ppm each corresponding to 
six methoxy protons appears as singlets. 
The 13C-NMR spectrum (101 MHz, DMSO d6), shows peaks 
similar to compound 1. However, there are two additional peaks 
that appear at δC 60.2 ppm and 56.3 ppm which are typical for 
two methoxy carbon. The 13C-NMR spectrum data provides 
information that 25 peaks, namely 181.5; 163.2; 158.9; 157.2; 
154.7; 154.7; 143.5; 136.5; 130.8; 130.5; 123.6; 122.2; 110.3; 
110.3; 102.7; 102.7; 89.5; 60.2; 56.3; 25.7; 25.7; 25.6; 20.9; 
18.0; 17.6. Furthermore, comparison of NMR data for 
compound 2 with NMR data for β-mangostin compound [14] as 
tabulated in Table 2 shows the similarity between the two. 
Based on UV-Vis, IR, HR-ESI-MS, 1H-NMR and 13C-NMR 
spectroscopy it can be concluded that compound 2 has one 
chelate hydroxy group, one free hydroxy group, two prenyl 
groups and two methoxy groups which are β- compounds 
mangostin (2) and can see Figure 11. 
D. Antidiabetic Test 
The test sample used 8-deoxygartanin (1) and β-mangostin 
(2), while the positive control used rootsbosa. The IC50 value is 
determined using a linear regression equation by changing the 
concentration into a log concentration. Calculation results can 
be seen in Table 3. and Figure 12. 
IV. CONCLUSION 
This research has explored two phenolic compounds, 8-
deoxigartanin (1) and β-mangostin (2) from n-hexane extract of 
mangosteen rind (Garcinia mangostana Linn.). Determination 
of the structure of the compound is carried out utilizing UV-
Vis, IR, HR-ESI-MS, and NMR spectroscopic techniques. The 
results of antidiabetic bioactivity tests on isolates 8-
deoxigartanin (1) and β-mangostin (2) resulted in IC50 values 
= 38.5 μM and 157.9 μM, respectively. 
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